---
category: news
title: "Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma"
excerpt: "PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR(Â®) artificial intelligence (\"A.I.\") platform to transform cancer drug development and identi"
publishedDateTime: 2020-12-17T12:00:00Z
originalUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_business/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further/article_9bda7c2d-0ed5-568b-9e5e-ddc977facb76.html"
webUrl: "https://www.wfmz.com/news/pr_newswire/pr_newswire_business/lantern-pharma-announces-collaboration-with-world-leading-brain-cancer-program-at-johns-hopkins-to-further/article_9bda7c2d-0ed5-568b-9e5e-ddc977facb76.html"
type: article
quality: 15
heat: 15
published: false

provider:
  name: WFMZ-TV
  domain: wfmz.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/assets/v3/editorial/2/90/290d9a51-9a5a-50e0-b093-3f61b545ed96/5fdb4f8c866a5.image.jpg?resize=400%2C296"
    width: 400
    height: 296
    isCached: true

secured: "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;MEDrq1PDII74o9DtbuadnA=="
---

